TY - JOUR
T1 - Synthesis and characterization of Au-decorated graphene oxide nanocomposite for magneto-electrochemical detection of SARS-CoV-2 nucleocapsid gene
AU - Malla, Pravanjan
AU - Liu, Chi Hsien
AU - Wu, Wei Chi
AU - Kabinsing, Pinpinut
AU - Sreearunothai, Paiboon
N1 - Copyright © 2023 Elsevier B.V. All rights reserved.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Fast and effective diagnosis is the first step in monitoring the current coronavirus 2 (CoV-2) pandemic. Herein, we establish a simple and sensitive electrochemical assay using magnetic nanocomposite and DNA sandwich probes to rapidly quantify the CoV-2 nucleocapsid (N) gene down to the 0.37 fM level. This assay uses a pair of specific DNA probes. The capture probe is covalently conjugated to Au-decorated magnetic reduced graphene oxide (AMrGO) nanocomposite for efficiently capturing target RNA. In contrast, the detection probe is linked to peroxidase for signal amplification. The probes target the COV-2 gene, allowing for specific magnetic separation, enzymatic signal amplification, and subsequent generation of voltammetric current with a total assay time of 45 min. The developed biosensor has high selectivity and can discriminate non-specific gene sequences. Synthetic COV-2 N-gene can be detected efficiently in serum and saliva, while 1-bp mismatch gene yielded a low response. The performance of the genosensor was good in an extensive linear range of 5 aM–50 pM. For synthetic N-gene, we achieved the detection limit of 0.37, 0.33, and 0.19 fM in human saliva, urine, and serum. This simple, selective, and sensitive genosensor could have various genetics-based biosensing and diagnostic applications.
AB - Fast and effective diagnosis is the first step in monitoring the current coronavirus 2 (CoV-2) pandemic. Herein, we establish a simple and sensitive electrochemical assay using magnetic nanocomposite and DNA sandwich probes to rapidly quantify the CoV-2 nucleocapsid (N) gene down to the 0.37 fM level. This assay uses a pair of specific DNA probes. The capture probe is covalently conjugated to Au-decorated magnetic reduced graphene oxide (AMrGO) nanocomposite for efficiently capturing target RNA. In contrast, the detection probe is linked to peroxidase for signal amplification. The probes target the COV-2 gene, allowing for specific magnetic separation, enzymatic signal amplification, and subsequent generation of voltammetric current with a total assay time of 45 min. The developed biosensor has high selectivity and can discriminate non-specific gene sequences. Synthetic COV-2 N-gene can be detected efficiently in serum and saliva, while 1-bp mismatch gene yielded a low response. The performance of the genosensor was good in an extensive linear range of 5 aM–50 pM. For synthetic N-gene, we achieved the detection limit of 0.37, 0.33, and 0.19 fM in human saliva, urine, and serum. This simple, selective, and sensitive genosensor could have various genetics-based biosensing and diagnostic applications.
KW - CoV-2
KW - Electrochemical biosensor
KW - Genosensor
KW - Nucleocapsid gene
KW - Reduced graphene oxide
KW - SARS-CoV-2/genetics
KW - Electrochemical Techniques
KW - Humans
KW - Nucleocapsid
KW - Graphite/chemistry
KW - Gold/chemistry
KW - COVID-19
KW - Biosensing Techniques
KW - Nanocomposites/chemistry
UR - https://www.scopus.com/pages/publications/85160428079
U2 - 10.1016/j.talanta.2023.124701
DO - 10.1016/j.talanta.2023.124701
M3 - 文章
C2 - 37235956
AN - SCOPUS:85160428079
SN - 0039-9140
VL - 262
SP - 124701
JO - Talanta
JF - Talanta
M1 - 124701
ER -